Updated Jul 16, 2026
Tucker John H is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
John H. Tucker is the President and CEO of scPharmaceuticals Inc., a company focused on developing and commercializing innovative therapies for patients with cardiovascular disease. He has a background in the pharmaceutical industry, although specific details about his career prior to scPharmaceuticals are not widely documented.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-07 | SCPH | scPharmaceuticals Inc. | D — Derivative transaction | 318.5K | — | |
| 2025-10-07 | SCPH | scPharmaceuticals Inc. | J — Other acquisition / disposition | 122.3K | — |
John H. Tucker is the President and CEO of scPharmaceuticals Inc., a company focused on developing and commercializing innovative therapies for patients with cardiovascular disease. He has a background in the pharmaceutical industry, although specific details about his career prior to scPharmaceuticals are not widely documented.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tucker John H profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.